Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HMB and Glutamine for Wound Healing in Type 2 Diabetes
NCT03782155Phase 4Unknown
- Sponsor
- Hospital General de México "Dr. Eduardo Liceaga"
- Start
- Jun 2021
- Primary completion
- Aug 2021
- Countries
- 1
01
Overview
Phase 4, randomised trial (2 arms), sponsored by Hospital General de México "Dr. Eduardo Liceaga". Primary endpoint: Wound healing: Number of cells per cluster in tissue sample of wound at 15 days. Status: unknown.
Beyond the preview
Go deeper on NCT03782155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03782155.